David Reese
Förmögenhet: 18 M $ per 2026-08-31
Förmögenhet: 18 M $ per 2026-08-31
David M.
Reese was the founder of Translational Oncology Research International, Inc., founded in 2003, where the title held was President & Chief Medical Officer from 2003 to 2005.
Current jobs include Chief Executive Officer at KAI Pharmaceuticals, Inc.; President & Director at Alantos Pharmaceuticals Holding, Inc.; President & Director at BioVex Group, Inc.; Director at CEO Roundtable on Cancer, Inc.; and Director at Research!America starting in 2023.
Former jobs include Chief Executive Officer at Onyx Pharmaceuticals, Inc., ChemoCentryx, Inc., and Five Prime Therapeutics, Inc.; Director-Clinical Research at Translational Research In Oncology; Director-Clinical Research at Breast Cancer International Research Group Ltd. from 2001 to 2003; and Chief Technology Officer & Executive Vice President at Amgen, Inc. from 2023 to 2026.
Education includes undergraduate studies at The University of Cincinnati College of Medicine and Harvard College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
AMGEN INC. 0,01 % | 2026-05-07 | 42 256 ( 0,01 % ) | 18 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | President | - |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Direktör/Styrelseledamot | - |
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Verkställande Direktör | - |
Alantos Pharmaceuticals Holding, Inc.
Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | President | - |
Research!America
Research!America Miscellaneous Commercial ServicesCommercial Services Operates as a lobbying firm | Direktör/Styrelseledamot | 2023-04-22 |
| Företag | Position | Slut |
|---|---|---|
| AMGEN INC. | Teknisk/Vetenskaplig/F&U Direktör | 2026-06-30 |
Translational Oncology Research International, Inc.
Translational Oncology Research International, Inc. Pharmaceuticals: MajorHealth Technology Engages in processing drugs in pharmaceutical preparations | Grundare | 2005-01-01 |
Breast Cancer International Research Group Ltd.
Breast Cancer International Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services The Cancer International Research Group (CIRG) is a not-for-profit academic research organization focused on oncology and is part of the TRIO group, which encompasses the Breast Cancer International Research Group and a clinical trial operations branch. The private company is based in Edmonton, Canada. CIRG offers clinical research services, managing studies from small dose-finding trials to large phase III registration trials. The organization supports clinical research across all phases of drug development, utilizing translational approaches based on the biology of diseases, and provides flexible services to meet various sponsor requirements. The Canadian company was founded by Alessandro Riva. | Företagsledare/Principal | 2003-01-01 |
| CHEMOCENTRYX, INC. | Verkställande Direktör | - |
| ░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░░ | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 14 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Alantos Pharmaceuticals Holding, Inc.
Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Commercial Services |
Research!America
Research!America Miscellaneous Commercial ServicesCommercial Services Operates as a lobbying firm | Commercial Services |
The University of Cincinnati College of Medicine
The University of Cincinnati College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Translational Research In Oncology
Translational Research In Oncology Miscellaneous Commercial ServicesCommercial Services Operates as an oncology clinical research organization | Commercial Services |
Translational Oncology Research International, Inc.
Translational Oncology Research International, Inc. Pharmaceuticals: MajorHealth Technology Engages in processing drugs in pharmaceutical preparations | Health Technology |
Breast Cancer International Research Group Ltd.
Breast Cancer International Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services The Cancer International Research Group (CIRG) is a not-for-profit academic research organization focused on oncology and is part of the TRIO group, which encompasses the Breast Cancer International Research Group and a clinical trial operations branch. The private company is based in Edmonton, Canada. CIRG offers clinical research services, managing studies from small dose-finding trials to large phase III registration trials. The organization supports clinical research across all phases of drug development, utilizing translational approaches based on the biology of diseases, and provides flexible services to meet various sponsor requirements. The Canadian company was founded by Alessandro Riva. | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån